Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Research & Development (2020 - 2025)

Dentsply Sirona's Research & Development history spans 6 years, with the latest figure at $40.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 4.76% year-over-year to $40.0 million, compared with a TTM value of $150.0 million through Dec 2025, down 9.09%, and an annual FY2025 reading of $150.0 million, down 9.09% over the prior year.
  • Research & Development for Q4 2025 was $40.0 million at Dentsply Sirona, up from $37.0 million in the prior quarter.
  • The five-year high for Research & Development was $49.0 million in Q4 2021, with the low at $36.0 million in Q1 2025.
  • Average Research & Development over 5 years is $42.2 million, with a median of $42.0 million recorded in 2024.
  • Year-over-year, Research & Development soared 115.0% in 2021 and then fell 16.33% in 2024.
  • Tracing XRAY's Research & Development over 5 years: stood at $49.0 million in 2021, then dropped by 12.24% to $43.0 million in 2022, then changed by 0.0% to $43.0 million in 2023, then decreased by 2.33% to $42.0 million in 2024, then decreased by 4.76% to $40.0 million in 2025.
  • Per Business Quant, the three most recent readings for XRAY's Research & Development are $40.0 million (Q4 2025), $37.0 million (Q3 2025), and $37.0 million (Q2 2025).